OHLCX Market Research

COR

COR is the ticker symbol for Cencora, Inc., a publicly traded company that provides pharmaceutical distribution and related services. It trades on a major U.S. stock exchange.

$330.84
+0.31 (+0.09%) Oct 30, 2026 04:00 AM
Open
336.79
High
340.19
Low
330.20
Prev close
330.53
Volume
1M
Avg vol 10
1M

Daily bar · Oct 30, 2026

Price

COR chart

Updating chart…

Scroll or pinch to zoom, drag to pan. About the price history

Signals

Technical analysis

Daily bars · last bar Oct 30, 2026 · close 330.84

Strong sellNeutralStrong buy
Buy
score +0.17 · 18 signalling
6Buy
9Neutral
3Sell

Leaning buy. 6 of 18 signals point up against 3 down, carried by trend and volume. Momentum is mostly neutral. Volatility is mostly neutral. Stoch RSI sits in oversold territory. Trend strength is weak (ADX 19).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 3.04 · Signal 4.10 · Hist −1.05
Sell
ADX 14
Weak trend, +DI ahead
ADX 18.68 · +DI 30.88 · −DI 22.93
Neutral
Parabolic SAR 0.02, 0.2
Below price, 10.78 under the close
320.06
Buy
Ichimoku 9, 26, 52
Price above cloud, conversion above base
Conv 332.53 · Base 320.24 · A 318.85 · B 317.50
Buy

Momentum

RSI 14
Mid-range, no extreme
54.14
Neutral
Stoch 14, 3
Mid-range, %K still above %D
%K 42.44 · %D 34.84
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K still above %D
%K 19.00 · %D 9.68
Buy
Williams %R 14
Mid-range, still rising
−57.56
Neutral
CCI 14
Negative, above −100
−14.94
Neutral
MFI 14
Below midpoint, not oversold
41.63
Neutral
ROC 12
Price down 1.59% over 12 bars
−1.59%
Sell
AO 5, 35
Above zero, falling
7.16
Neutral
TRIX 18
Above zero
0.156
Buy
KST 10/15/20/30, 3
Below its signal line
KST 51.96 · Signal 54.10
Sell

Volatility

Bollinger 20, 2
Upper half, %b 0.52
Up 347.47 · Mid 330.08 · Low 312.69
Neutral
Keltner 20, 10, 1.5
Inside the channel, upper half
Up 339.50 · Mid 328.84 · Low 318.19
Neutral

Volume

VWAP 345-bar
Close 5.4% above VWAP
313.98
Buy
Force Index 1
Positive, buyers in control
418.0K
Buy
ATR
7.15
2.16% of close
A/D Line
13.3M
cumulative
OBV
−2.6M
cumulative
Volume Profile
292.22 – 301.70
POC · bull 60.1M · bear 55.5M · 52 / 48
Risk and return

Performance

Daily returns for Jan 1, 2026 – Oct 31, 2026 (YTD). About the returns · About the risk figures

1 month return

6.80%

Change in value over the past month.

3 month return

6.26%

Change in value over the last three months.

Max drawdown

32.18%

Largest fall from a peak to the low that followed.

Standard deviation

32.96%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.08

Return above the risk-free rate per unit of volatility.

Calmar ratio

0.09

Annualised return against the maximum drawdown.

About

COR summary

Loading summary…

Questions

COR, answered

How does COR compare with similar securities?

COR may be compared to other pharmaceutical distribution companies, with performance metrics reflecting its operational efficiency and market position relative to its peers.

What sectors or markets is COR exposed to?

COR is primarily exposed to the healthcare and pharmaceutical sectors, which can be affected by changes in healthcare policies and market demand.

What is the liquidity of COR and how does it trade?

COR's liquidity is determined by its trading volume, which can indicate how easily shares can be bought or sold in the market.

What drives the performance of COR?

The performance of COR is influenced by factors such as demand for pharmaceutical products, regulatory changes, and the overall healthcare market environment.

What are the main risks associated with COR?

Main risks for COR include regulatory risks, supply chain disruptions, and competition within the pharmaceutical distribution industry.

What can a reader see on the OHLCX Markets page for COR?

On the OHLCX Markets page for COR, a reader can view a price chart, technical analysis indicators, and various performance metrics that provide insights into the stock's historical performance.

What costs or structure should a holder of COR know about?

Holders of COR should be aware of potential trading commissions, management fees, and any tax implications associated with their investment.

What should a reader check before trading COR?

Before trading COR, a reader should check the latest news, financial statements, and market conditions that may impact the stock's performance.

How is COR managed or what does Cencora, Inc. do?

Cencora, Inc. operates in the healthcare sector, focusing on the distribution of pharmaceuticals and providing services that support healthcare providers and patients.

News

COR in the news

Improve Your COR Trading Now

Empower your trading with OHLCX. Our comprehensive platform delivers precise analysis and strategic insights for COR, designed to improve your trading outcomes. Transform your trading strategy now and unlock new opportunities with our advanced system!

Take Action Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.